REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,019,137 | +660.5% | 29,611 | +650.4% | 0.00% | – |
| Q3 2021 | $397,000 | -67.4% | 3,946 | -49.5% | 0.00% | -100.0% |
| Q2 2020 | $1,219,000 | -73.3% | 7,810 | -75.3% | 0.00% | -80.0% |
| Q1 2020 | $4,573,000 | -55.3% | 31,680 | -36.7% | 0.01% | -41.2% |
| Q4 2019 | $10,225,000 | +118.7% | 50,016 | -14.1% | 0.02% | +88.9% |
| Q3 2019 | $4,676,000 | -4.5% | 58,236 | +12.2% | 0.01% | 0.0% |
| Q2 2019 | $4,898,000 | +125.0% | 51,917 | +103.8% | 0.01% | +125.0% |
| Q1 2019 | $2,177,000 | -17.8% | 25,476 | -46.0% | 0.00% | -33.3% |
| Q4 2018 | $2,648,000 | +906.8% | 47,198 | +1364.9% | 0.01% | – |
| Q3 2018 | $263,000 | – | 3,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |